Stockscreener 앱 받기
244.76
0.13%
0.32
시간 외 거래:
244.76
Resmed Inc 주식(RMD)의 최신 뉴스
ResMed Inc. $RMD Stock Holdings Raised by Pacer Advisors Inc. - MarketBeat
Why analysts maintain buy rating on ResMed Inc. (RME) stockGlobal Market Influence & Big Gains Small Capital - bollywoodhelpline.com
ResMed Officer Plans Further Share Sale Under Rule 144 - MSN
ResMed Inc. (NYSE:RMD) Given Average Rating of "Moderate Buy" by Analysts - MarketBeat
Voya Investment Management LLC Has $8.97 Million Position in ResMed Inc. $RMD - MarketBeat
Swedbank AB Increases Stock Position in ResMed Inc. $RMD - MarketBeat
Is ResMed stock underperforming the S&P 500? - MSN
Why ResMed (RMD) is a Top Growth Stock for the Long-Term - Yahoo Finance
OLD National Bancorp IN Increases Stock Holdings in ResMed Inc. $RMD - MarketBeat
Patton Fund Management Inc. Has $265,000 Stock Holdings in ResMed Inc. $RMD - MarketBeat
Confluence Investment Management LLC Sells 4,405 Shares of ResMed Inc. $RMD - MarketBeat
Thrivent Financial for Lutherans Acquires 5,212 Shares of ResMed Inc. $RMD - MarketBeat
The Bull Case For ResMed (RMD) Could Change Following FDA-Cleared AI Smart Comfort CPAP Feature - Sahm
Texas Permanent School Fund Corp Sells 5,560 Shares of ResMed Inc. $RMD - MarketBeat
Assenagon Asset Management S.A. Sells 5,635 Shares of ResMed Inc. $RMD - MarketBeat
Will ResMed Inc. (Common Stock) (RMEA) stock beat revenue estimatesPortfolio Performance Report & Intraday High Probability Alerts - ulpravda.ru
Technical Analysis: Will ResMed Inc. stock gain from strong economyTrend Reversal & Weekly High Return Stock Forecasts - ulpravda.ru
Is ResMed Inc. stock attractive for long term wealth buildingJuly 2025 Price Swings & Real-Time Volume Analysis - DonanımHaber
Will ResMed Inc. stock deliver better than expected guidanceJuly 2025 Movers & Long Hold Capital Preservation Tips - DonanımHaber
Resmed Inc Officer Plans Sale of Common Stock - MSN
Will ResMed Inc. stock attract more institutional investorsMarket Volume Report & Real-Time Volume Triggers - Улправда
Will ResMed Inc. stock benefit from automationQuarterly Trade Review & Growth-Oriented Investment Plans - DonanımHaber
Why ResMed Inc. stock is a value investor pickJuly 2025 Short Interest & Smart Money Movement Tracker - Улправда
ResMed Inc. $RMD Shares Acquired by Addenda Capital Inc. - MarketBeat
Healthcare Equipment Focus as ResMed Appears in ASX 100 Landscape - Kalkine Media
Is ResMed Inc. stock in correction or buying zoneJuly 2025 Setups & Daily Technical Forecast Reports - Улправда
ResMed Inc. stock falls Thursday, underperforms market - MarketWatch
Resmed Announces Participation in the 44th Annual J.P. Morgan Healthcare Conference - marketscreener.com
Two Resmed leaders take the J.P. Morgan Healthcare Conference stage - Stock Titan
ResMed (FRA:RMEA) EV-to-OCF : 17.84 (As of Dec. 18, 2025) - GuruFocus
Is It Too Late to Consider ResMed After Weight Loss Drug Concerns and DCF Outlook? - Sahm
Stifel Maintains ResMed (RMD) Hold Recommendation - Nasdaq
Will ResMed Inc. (RME) stock outperform Dow Jones2025 Momentum Check & Community Trade Idea Sharing Platform - Улправда
Stifel Nicolaus Adjusts ResMed Price Target to $260 From $270, Maintains Hold Rating - marketscreener.com
Stifel Lowers Price Target for ResMed (RMD) to $260, Maintains H - GuruFocus
How ResMed Inc. stock performs in easing cyclesJuly 2025 WrapUp & AI Driven Price Predictions - Улправда
Aug Volume: Can ResMed Inc. stock double in next 5 yearsGold Moves & Reliable Intraday Trade Alerts - Улправда
ResMed stock price target lowered to $260 by Stifel on Philips return concerns - Investing.com UK
ResMed Director Acquires Additional Shares in Strategic Move - MSN
ResMed (RMD): Revisiting Valuation After Recent Share Price Pullback - Yahoo Finance
ResMed (NYSE:RMD) Downgraded to "Hold" Rating by Baird R W - MarketBeat
4,600 Shares in ResMed Inc. $RMD Purchased by Sanders Morris Harris LLC - MarketBeat
Tandem upgraded, Zimmer, ResMed downgraded as Baird previews MedTech in 2026 - MSN
ResMed Inc. stock falls Tuesday, underperforms market - MarketWatch
Shorts Report: Will ResMed Inc stock benefit from automationWeekly Profit Analysis & Breakout Confirmation Trade Signals - moha.gov.vn
ResMed (RMD) Downgraded by Baird, Price Target Lowered to $275 | - GuruFocus
Baird Downgrades ResMed to Neutral From Outperform, Adjusts Price Target to $275 From $300 - marketscreener.com
Baird downgrades ResMed stock rating to Neutral on slowing growth By Investing.com - Investing.com Australia
Baird downgrades ResMed stock rating to Neutral on slowing growth - Investing.com
ResMed (RMD): Evaluating the Stock’s Valuation After FDA Clearance for Its AI-Powered Smart Comfort CPAP Feature - Sahm
Mick Farrell, Chairman and CEO of Resmed, Named Chair of AdvaMed Board of Directors - WebWire
ResMed Inc. $RMD Shares Acquired by Neuberger Berman Group LLC - MarketBeat
MASTERINVEST Kapitalanlage GmbH Takes $3.02 Million Position in ResMed Inc. $RMD - MarketBeat
FORA Capital LLC Purchases New Stake in ResMed Inc. $RMD - MarketBeat
ResMed Inc announces proposed sale of securities by director - MSN
How FDA-Cleared AI Smart Comfort Personalization At ResMed (RMD) Has Changed Its Investment Story - Sahm
What analysts say about ResMed Inc stockEarnings Call Summaries & Breakthrough Profit Margins - earlytimes.in
Loss Report: Will ResMed Inc stock benefit from automationJuly 2025 Recap & Reliable Breakout Stock Forecasts - moha.gov.vn
ResMed stock price target raised to $345 from $335 at UBS - Investing.com
Ilex Capital Partners UK LLP Takes $39.31 Million Position in ResMed Inc. $RMD - MarketBeat
Bayesian Capital Management LP Buys Shares of 17,316 ResMed Inc. $RMD - MarketBeat
AdvaMed Names Resmed CEO Mick Farrell as Next Board Chair - Medical Product Outsourcing
ResMed Inc. $RMD Shares Sold by Frontier Capital Management Co. LLC - MarketBeat
ResMed Inc. $RMD Shares Purchased by State Street Corp - MarketBeat
0.34%
0.26%
자본화:
|
볼륨(24시간):